Disclosures for "Updated Characterization of Clinical and Immunological Endotypes in Acetylcholine Receptor–Positive Myasthenia Gravis: Expanded Analysis of 601 Patients"
-
Dr. Oved has received personal compensation for serving as an employee of Canopy Immuno Therapeutics .
-
Dr. Denkberg has received personal compensation for serving as an employee of Canopy Immuno-Therapeutics. Dr. Denkberg has received intellectual property interests from a discovery or technology relating to health care.
-
Miss Pinzur has received personal compensation for serving as an employee of Canopy Immuno-Therapeutics.
-
Dr. Arman has nothing to disclose.
-
Dr. Mazor has received personal compensation for serving as an employee of Canopy Immunotherapeutics. Dr. Mazor has stock in Canopy Immunotherapeutics.
-
Dr. Reef has received personal compensation for serving as an employee of Canopy Immuno-Therapeutics. Dr. Reef has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Harel has received personal compensation for serving as an employee of Canopy Immunotherapeutics.
-
Miss Erez has nothing to disclose.
-
Ms. Atiya has nothing to disclose.
-
Dr. Dowery has nothing to disclose.
-
The institution of Dr. Lazaridis has received research support from Toleranzia AB.
-
Dr. Wilf-Yarkoni has nothing to disclose.